BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16216245)

  • 1. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.
    Gizard F; Robillard R; Gervois P; Faucompré A; Révillion F; Peyrat JP; Hum WD; Staels B
    FEBS Lett; 2005 Oct; 579(25):5535-41. PubMed ID: 16216245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.
    Gizard F; Robillard R; Barbier O; Quatannens B; Faucompré A; Révillion F; Peyrat JP; Staels B; Hum DW
    Mol Cell Biol; 2005 Jun; 25(11):4335-48. PubMed ID: 15899840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
    Cen B; Deguchi A; Weinstein IB
    Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study.
    Huang CS; Ho WL; Lee WS; Sheu MT; Wang YJ; Tu SH; Chen RJ; Chu JS; Chen LC; Lee CH; Tseng H; Ho YS; Wu CH
    Biochem Pharmacol; 2008 May; 75(9):1783-96. PubMed ID: 18355800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.
    Takahashi A; Kato K; Kuboyama A; Inoue T; Tanaka Y; Kuhara A; Kinoshita K; Takeda S; Wake N
    Gynecol Oncol; 2009 May; 113(2):270-6. PubMed ID: 19211137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression.
    Mayo C; Lloreta J; Real FX; Mayol X
    J Cell Physiol; 2007 Jul; 212(1):42-50. PubMed ID: 17311291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiprogestin Lonaprisan inhibits breast cancer cell proliferation by inducing p21 expression.
    Busia L; Faus H; Hoffmann J; Haendler B
    Mol Cell Endocrinol; 2011 Feb; 333(1):37-46. PubMed ID: 21138753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium.
    Lecanda J; Parekh TV; Gama P; Lin K; Liarski V; Uretsky S; Mittal K; Gold LI
    Cancer Res; 2007 Feb; 67(3):1007-18. PubMed ID: 17283133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
    Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
    Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.